Background illustration for clinical trials search

Paid Clinical Trials Houston

Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

for
Alzheimer Disease, Agitation
Location: Cypress TX, Carrollton TX, El Paso TX, Tampa FL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT06937229

Phase 3, Recruiting

Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

for
Diabete Mellitus, Foot Ulcer Chronic
Location: Houston TX, Phoenix AZ
Sponsor: BioXTek

Sex: All

Age: 45 - 70+

Code: NCT07326553

Recruiting

Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

for
Aneurysm, Aneurysm, Intracranial
Location: Galveston TX, Memphis TN, Kansas City KS,
Sponsor: Stryker Neurovascular

Sex: All

Age: 18 - 70+

Code: NCT06872684

Recruiting

A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations

for
Pilot Study, PET/CT Imaging, Host Disease Manifestation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07325253

Phase 2, Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

for
IgAN, C3G, Complement-mediated Kidney Disease,
Location: Houston TX, Iowa City IA, Dakota Dunes SD, Shelby MI,
Sponsor: ADARx Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06989359

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Houston TX, Seabrook TX, Round Rock TX, Austin TX,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase 2, Recruiting

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

for
Glioblastoma Multiforme of Brain
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 21 - 70

Code: NCT06815432

Phase 1, Recruiting

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Houston TX, Columbia MO, Gainesville FL, Tampa FL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07155174

Phase 2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Houston TX, Dallas TX, Baton Rouge LA, Overland Park KS,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

for
Metastatic Colorectal Cancer, Advanced Colorectal Cancer
Location: Kingwood TX, Nashville TN, Las Vegas NV, Newark DE
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT06824064

Phase 2, Recruiting

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

for
Prosthetic-joint Infection
Location: Katy TX, Shreveport LA, Dallas TX, Edinburg TX,
Sponsor: Peptilogics

Sex: All

Age: 18 - 70+

Code: NCT07214311

Phase 2, Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

for
Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-),
Location: Houston TX, Sugar Land TX, League City TX, Conroe TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07318805

Phase 1, Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma, RCC,
Location: Houston TX, Dallas TX, St Louis MO, Omaha NE, Miami FL,
Sponsor: Neomorph, Inc

Sex: All

Age: 18+

Code: NCT07300241

Phase 1, Recruiting

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

for
Clear Cell Renal Cell Carcinoma
Location: Houston TX, Ann Arbor MI
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07187778

Phase 2, Recruiting

Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07042685

Phase 2, Recruiting

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX, San Antonio TX, Dallas TX, Fort Worth TX,
Sponsor: Children's Oncology Group

Sex: All

Age: 2 - 18

Code: NCT05711667

Phase 3, Recruiting

Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

for
Malignant Neoplasms of Respiratory and Intrathoracic Organs,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03114462

Phase 1, Recruiting

Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

for
Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 0+

Code: NCT05046080

Recruiting

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

for
EGFR Mutation Positive Non-small Cell Lung Cancer,
Location: Houston TX, Pittsburgh PA, Fairfax VA, Calverton MD,
Sponsor: Nuvectis Pharma, Inc.

Sex: All

Age: 18+

Code: NCT07315113

Phase 1, Recruiting

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

for
High Risk Myelodysplastic Syndrome,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03214562

Phase 1, Phase 2, Recruiting
Article preview image

Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country

Houston Has More Recruiting Clinical Trials Than Any US City